Hawaii Headache & Facial Pain Center awarded Research to Investigate XEOMIN® (incobotulinumtoxinA) for Prevention of Chronic and Episodic Migraine
The Hawaii Headache & Facial Pain Center and Hawaii Headache Research Unit have been awarded a clinical research study to investigate XEOMIN® (incobotulinumtoxinA) as a potential preventive treatment for chronic and episodic migraine. This important research initiative aims to address ongoing gaps in migraine prevention and expand treatment options for patients in Hawaiʻi . Understanding […]